Shares of Canadian cannabis producer Tilray posted their second-best day ever after the company announced approval from the Drug Enforcement Administration to import marijuana to the United States for medical research.
The company's U.S.-listed shares jumped 28.9 percent Tuesday with 19 million of the company's 21.7 million floating shares exchanging hands. Shares are up over 400 percent in the past month.
Tilray will work with the University of California San Diego Center for Medicinal Cannabis Research to study the safety, tolerability and efficacy of marijuana for a neurological disorder.
Top Image: © Travis | Adobe Stock
